EVALUATION OF EXOSOME-DERIVED CircRNA EXPRESSION PATTERNS IN LUNG CANCER RADIOTHERAPY

Background: Radiotherapy is an effective method used in the treatment of lung cancer. However, it is very difficult to assess the clinical manifestations of radiotherapy at an early stage and the relevant criteria are very limited. Exosome-derived circRNAs (exo-circRNAs) have potential as biomarkers for early a cancer diagnosis and treatment assessment as exosomes are present in a variety of body fluids and circRNAs in exosomes exhibit high stability. Therefore, we aimed to investigate for potential biomarker candidates by evaluating changes in exo-circRNA expression with radiotherapy in lung cancer. Method: In this study, lung cancer epithelial (A549) and healthy lung fibroblast (WI38) cell lines were used. After colony assay, both cell lines were irradiated with 4 Gy and exosomes were isolated by ultracentrifugation method. Exosomes were characterized by flow cytometry and nanoparticle tracking analysis, and RNA isolation was performed by trizol protocol. Then, the expression levels of 40 exo-circRNAs in all groups were examined by RT-qPCR. Results: Of the exosomal circRNA investigated, 5 exo-circRNAs were found to be expressed in at least one of the groups, including A549, WI38, irradiated A549 and irradiated WI-38 cell lines. In particular, hsa_circ_0014235 and hsa_circ_0001900, which were found to be expressed in all groups, were more upregulated in cancer cell lines than healthy cell line. Significant changes were detected in the expression levels of these exo-circRNAs after irradiation. Conclusions: Differential expression of exo-circRNAs between cancer and healthy group and alterations by irradiation suggests that they may be potential diagnostic and monitoring biomarkers in cancer.

EVALUATION OF EXOSOME-DERIVED CircRNA EXPRESSION PATTERNS IN LUNG CANCER RADIOTHERAPY

Background: Radiotherapy is an effective method used in the treatment of lung cancer. However, it is very difficult to assess the clinical manifestations of radiotherapy at an early stage and the relevant criteria are very limited. Exosome-derived circRNAs (exo-circRNAs) have potential as biomarkers for early a cancer diagnosis and treatment assessment as exosomes are present in a variety of body fluids and circRNAs in exosomes exhibit high stability. Therefore, we aimed to investigate for potential biomarker candidates by evaluating changes in exo-circRNA expression with radiotherapy in lung cancer. Method: In this study, lung cancer epithelial (A549) and healthy lung fibroblast (WI38) cell lines were used. After colony assay, both cell lines were irradiated with 4 Gy and exosomes were isolated by ultracentrifugation method. Exosomes were characterized by flow cytometry and nanoparticle tracking analysis, and RNA isolation was performed by trizol protocol. Then, the expression levels of 40 exo-circRNAs in all groups were examined by RT-qPCR. Results: Of the exosomal circRNA investigated, 5 exo-circRNAs were found to be expressed in at least one of the groups, including A549, WI38, irradiated A549 and irradiated WI-38 cell lines. In particular, hsa_circ_0014235 and hsa_circ_0001900, which were found to be expressed in all groups, were more upregulated in cancer cell lines than healthy cell line. Significant changes were detected in the expression levels of these exo-circRNAs after irradiation. Conclusions: Differential expression of exo-circRNAs between cancer and healthy group and alterations by irradiation suggests that they may be potential diagnostic and monitoring biomarkers in cancer.

___

  • Grozescu T, Popa F. Prostate cancer between prognosis and adequate/proper therapy. J Med Life. 2017;10(1):5-12
Sağlık Bilimlerinde İleri Araştırmalar Dergisi-Cover
  • Yayın Aralığı: Yılda 3 Sayı
  • Başlangıç: 2018
  • Yayıncı: İstanbul Üniversitesi
Sayıdaki Diğer Makaleler

S-100 PROTEIN EXPRESSION LEVELS AS A POTENTIAL PROGNOSTIC MARKER IN NEUROBLASTOMA

Gamze SANLAV, Burçin BARAN, Deniz KIZMAZOĞLU, Selen KUM ÖZŞENGEZER, Safiye AKTAŞ, Zekiye ALTUN, Nur OLGUN

EXOSOMES – A NEW FRONTIER IN CANCER THERAPY

Sevgi GEZİCİ

INVESTIGATION OF THE EXPRESSION LEVEL OF miR 142-3P IN OVARIAN CARCINOMA

Yasemin GIDER, Khariqa JABBARLİ, Gamze UYAROĞLU, Demet AKDENİZ ÖDEMİŞ, Buğra TUNCER, Büşra KURT, Seda KILIÇ ERCİYAS, Özge ŞÜKRÜOĞLU ERDOĞAN, Betül ÇELİK, Hülya YAZICI

EPIGENETIC MECHANISMS OF SOY ISOFLAVONES IN PROSTATE CANCER TREATMENT

Omer KUCUK

IMPACT OF COMPREHENSIVE GENOMIC PROFILING NGS PANELS IN PRECISION ONCOLOGY: THE CITY OF HOPE CMDL EXPERIENCE

Milhan TELATAR

EFFECT OF THYMOQUINONE IN COMBINATION WITH NIVOLUMAB ON EXPERIMENTAL RENAL CELL CANCER MODELS

Ahmet DİRİCAN, Safiye AKTAŞ, Tekincan Çağrı AKTAŞ, Aylin EROL, Özde Elif GÖKBAYRAK, Efsun KOLATAN, Efe Özgür SERİNAN, Zekiye ALTUN, Işıl SOMALI, Osman YILMAZ

miR-3653-3P EXPRESSION IN PERIPHERAL BLOOD OF PATIENTS WITH OVARIAN CARCINOMA

Fatma Seher PEKTOPAL DELEK, Demet AKDENİZ ÖDEMİŞ, Özge ŞÜKRÜOĞLU ERDOĞAN, Seda KILIÇ ERCİYAS, Büşra KURT, Şeref Buğra TUNÇER, Hülya YAZICI

miRNA-REGULATED PATHWAYS OF CD8+T CELLS IN TNBC MOUSE MODEL

Muge OCAL-DEMİRTAS, Doç. Dr. Bala GÜR DEDEOĞLU

METHYLATION AND EXPRESSION VALIDATION RESULTS OF GPRC5C GENE OBTAINED FROM EPIGENOMICS AND TRANSCRIPTOMICS DATA IN ORAL CAVITY TUMORS

Gizem ESENTÜRK, Can DORUK, Murat ULUSAN, Nejat Vakur OLGAÇ, Semra DEMOKAN

LONG NON-CODING RNAs AND AUTOPHAGY IN OSTEOSARCOMA

Ayça COŞKUN, Hamza Malik OKUYAN